ENGLISH ABSTRACT
Add like
Add dislike
Add to saved papers

[New international classification of chronic pancreatitis (2007) M-ANNHEIM].

Beginning in 1963, proposed various classifications of chronic pancreatitis. These classifications were based on the latest at the time the results of studies of the pancreas and to reflect the latest achievements pancreatology at the time, but not one of these classifications was not a simple unified classification system for chronic pancreatitis simultaneously etiology, clinical stage, severity of disease. The authors have developed a new classification that included all of the above listed characteristics. As a result, developed a multifactor classification of M-ANNHEIM, taking into account the many risk factors for CP. This classification allows to divide the patients with chronic pancreatitis into categories according to etiology, clinical stage and severity of CP. The severity of the disease is classified by the system of assessment, which takes into account the clinical symptoms and treatment options for CP. This new classification is optimal for the evaluation of various risk factors and their interactions.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app